Curiosis

494120 · KQ · Healthcare / Medical Devices

11,870.00KRW-1410.00 (-10.62%)

Price History

Full chart

Market Stats

Previous Close13,280.00

Open13,430.00

Day Range11,780.00 – 13,590.00

52-Week Range7,450.00 – 48,200.00

Volume324.32K

Market Cap148.78B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

50-Day Avg9,474.40

200-Day Avg21,338.73

About

Curiosis, Inc. develops, produces, and supplies laboratory equipment in the field of life science. It offers cell imaging, cell counting, cell isolation, and digital pathology products. The company was incorporated in 2015 and is based in Seoul, South Korea.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Hoyoung Yun Ph.D.
Employees96
Headquarters10 Teheran-ro 38-gil, Seoul, South Korea, 06221, Korea
Websitehttps://www.curiosis.com

Leadership

Mr. Hoyoung Yun Ph.D.CEO, President & Director · b. 1980
Mr. Daesung Hur M.S.COO, Executive VP & Director · b. 1970
Mr. Youngho Park Ph.D.Senior VP & CTO · b. 1979
Mr. Heedon Ahn M.B.A.CSO & Executive VP · b. 1968
Mr. Jungmin Cho M.B.A.Senior VP & Head of Sales and Marketing Division · b. 1978
Mr. Changyong Um Ph.D.Executive VP, CRO & Director · b. 1969
Mr. Chihyoung Shim M.S.VP & Head of Information Security Dept. · b. 1981
Mr. SungUk ChoiAuditor · b. 1976
Dongyoub Baek Ph.D.Director & Head of SW Dept.
Seungjung Song Ph.D.Director & Head of Bio Dept.

Financials

Income Statement

Currency: KRW	2024-12-31	2025-12-31
Total Revenue	5.41B	7.30B
Growth (%)	-	+34.86%
Cost of Revenue	3.20B	3.82B
Gross Profit	2.21B	3.49B
Gross Margin	40.85%	47.74%
Operating Expense	8.41B	11.01B
Operating Income	-6.20B	-7.53B
Operating Margin	-114.54%	-103.05%
EBITDA	-2.21B	-6.64B
EBITDA Margin	-40.80%	-90.99%
Net Income	-4.82B	-7.86B
Net Income Margin	-88.97%	-107.69%
R&D	2.41B	4.48B
R&D as % of Total Revenue	44.48%	61.37%
Interest Expense	1.57B	255.21M
Interest Expense % of Total Revenue	28.98%	3.49%

Balance Sheet

Currency: KRW	2024-12-31	2025-12-31
Total Assets	17.37B	34.23B
Total Liabilities	7.66B	6.03B
Total Equity	9.71B	28.20B
Cash	9.23B	23.76B

Cash Flow

Currency: KRW	2024-12-31	2025-12-31
Operating Cash Flow	-4.78B	-7.35B
Capital Expenditure	460.35M	2.31B
Free Cash Flow	-5.24B	-9.66B
FCF to OCF	109.64%	131.40%

Earnings

Report Date	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-
EPS Actual	-148.29	-96.86	-136.52
Surprise	-	-	-
Timing	-	-	-

Key Statistics & Ratios

Market Cap148.78B

Enterprise Value109.68B

Trailing P/E0.00

Forward P/E0.00

Price / Sales17.60

Price / Book5.04

Revenue (TTM)8.45B

Gross Profit (TTM)2.66B

EBITDA-6.80B

Profit Margin-93.32%

Operating Margin-53.82%

Return on Equity-50.35%

Return on Assets-21.40%

Shares Outstanding15.26M

Shares Float11.07M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jul 15, 20262:1